re: not in big trouble -ignore panic merchants.... ...latest cash flow report shows reduced burn rate; eyecare distribution network now substantially in place; proceeding to NASDAQ listing; US investors building their stake. Immunology worth 55 cents per share alone!
Australian knockers have been getting out - check your broker as to who main selling broker has been in past six months -tells a story in itself I think.
